vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and MITEK SYSTEMS INC (MITK). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $44.2M, roughly 1.1× MITEK SYSTEMS INC). MITEK SYSTEMS INC runs the higher net margin — 6.3% vs -4.8%, a 11.0% gap on every dollar of revenue. On growth, MITEK SYSTEMS INC posted the faster year-over-year revenue change (18.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $6.6M). Over the past eight quarters, MITEK SYSTEMS INC's revenue compounded faster (-2.9% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Mitek Systems, Inc. is a software company that specializes in digital identity verification and mobile image processing using artificial intelligence. The company's software is used for depositing checks and opening bank accounts via mobile devices. It also verifies identity documents such as passports, ID cards, and driver's licenses by analyzing a selfie of an individual holding their ID, comparing their face to the photo on the document.

IRWD vs MITK — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.1× larger
IRWD
$47.7M
$44.2M
MITK
Growing faster (revenue YoY)
MITK
MITK
+66.1% gap
MITK
18.8%
-47.3%
IRWD
Higher net margin
MITK
MITK
11.0% more per $
MITK
6.3%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$68.0M more FCF
IRWD
$74.6M
$6.6M
MITK
Faster 2-yr revenue CAGR
MITK
MITK
Annualised
MITK
-2.9%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRWD
IRWD
MITK
MITK
Revenue
$47.7M
$44.2M
Net Profit
$-2.3M
$2.8M
Gross Margin
Operating Margin
14.3%
12.3%
Net Margin
-4.8%
6.3%
Revenue YoY
-47.3%
18.8%
Net Profit YoY
-200.9%
160.1%
EPS (diluted)
$0.01
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
MITK
MITK
Q4 25
$47.7M
$44.2M
Q3 25
$122.1M
$44.8M
Q2 25
$85.2M
$45.7M
Q1 25
$41.1M
$51.9M
Q4 24
$90.5M
$37.3M
Q3 24
$91.6M
$43.2M
Q2 24
$94.4M
$45.0M
Q1 24
$74.9M
$47.0M
Net Profit
IRWD
IRWD
MITK
MITK
Q4 25
$-2.3M
$2.8M
Q3 25
$40.1M
$1.9M
Q2 25
$23.6M
$2.4M
Q1 25
$-37.4M
$9.2M
Q4 24
$2.3M
$-4.6M
Q3 24
$3.6M
$8.6M
Q2 24
$-860.0K
$216.0K
Q1 24
$-4.2M
$282.0K
Operating Margin
IRWD
IRWD
MITK
MITK
Q4 25
14.3%
12.3%
Q3 25
61.8%
10.5%
Q2 25
53.2%
8.3%
Q1 25
-70.7%
21.9%
Q4 24
34.8%
-8.3%
Q3 24
28.0%
17.8%
Q2 24
26.5%
1.6%
Q1 24
14.7%
1.5%
Net Margin
IRWD
IRWD
MITK
MITK
Q4 25
-4.8%
6.3%
Q3 25
32.8%
4.2%
Q2 25
27.7%
5.2%
Q1 25
-90.9%
17.6%
Q4 24
2.5%
-12.4%
Q3 24
4.0%
19.8%
Q2 24
-0.9%
0.5%
Q1 24
-5.6%
0.6%
EPS (diluted)
IRWD
IRWD
MITK
MITK
Q4 25
$0.01
$0.06
Q3 25
$0.23
$0.04
Q2 25
$0.14
$0.05
Q1 25
$-0.23
$0.20
Q4 24
$0.03
$-0.10
Q3 24
$0.02
$0.19
Q2 24
$-0.01
$0.00
Q1 24
$-0.03
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
MITK
MITK
Cash + ST InvestmentsLiquidity on hand
$215.5M
$190.1M
Total DebtLower is stronger
$4.8M
Stockholders' EquityBook value
$-261.8M
$233.7M
Total Assets
$396.9M
$446.5M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
MITK
MITK
Q4 25
$215.5M
$190.1M
Q3 25
$140.4M
$193.0M
Q2 25
$92.9M
$167.1M
Q1 25
$108.5M
$136.2M
Q4 24
$88.6M
$121.2M
Q3 24
$88.2M
$130.3M
Q2 24
$105.5M
$123.1M
Q1 24
$121.5M
$123.9M
Total Debt
IRWD
IRWD
MITK
MITK
Q4 25
$4.8M
Q3 25
$199.5M
$4.3M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
$2.7M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
IRWD
IRWD
MITK
MITK
Q4 25
$-261.8M
$233.7M
Q3 25
$-264.2M
$240.3M
Q2 25
$-308.2M
$237.6M
Q1 25
$-334.1M
$220.2M
Q4 24
$-301.3M
$200.9M
Q3 24
$-311.3M
$214.8M
Q2 24
$-321.7M
$209.6M
Q1 24
$-330.5M
$216.1M
Total Assets
IRWD
IRWD
MITK
MITK
Q4 25
$396.9M
$446.5M
Q3 25
$396.1M
$459.1M
Q2 25
$342.9M
$446.7M
Q1 25
$327.2M
$425.3M
Q4 24
$350.9M
$396.0M
Q3 24
$389.5M
$413.8M
Q2 24
$395.6M
$409.2M
Q1 24
$438.8M
$417.0M
Debt / Equity
IRWD
IRWD
MITK
MITK
Q4 25
0.02×
Q3 25
0.02×
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
MITK
MITK
Operating Cash FlowLast quarter
$74.6M
$8.0M
Free Cash FlowOCF − Capex
$74.6M
$6.6M
FCF MarginFCF / Revenue
156.3%
14.9%
Capex IntensityCapex / Revenue
0.0%
3.2%
Cash ConversionOCF / Net Profit
2.89×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$60.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
MITK
MITK
Q4 25
$74.6M
$8.0M
Q3 25
$47.6M
$19.5M
Q2 25
$-15.1M
$21.6M
Q1 25
$20.0M
$13.7M
Q4 24
$15.2M
$565.0K
Q3 24
$9.9M
$21.1M
Q2 24
$33.5M
$13.0M
Q1 24
$45.0M
$7.1M
Free Cash Flow
IRWD
IRWD
MITK
MITK
Q4 25
$74.6M
$6.6M
Q3 25
$47.6M
$19.2M
Q2 25
$-15.1M
$21.2M
Q1 25
$19.9M
$13.5M
Q4 24
$230.0K
Q3 24
$9.9M
$20.8M
Q2 24
$33.4M
$12.6M
Q1 24
$44.9M
$6.6M
FCF Margin
IRWD
IRWD
MITK
MITK
Q4 25
156.3%
14.9%
Q3 25
39.0%
42.9%
Q2 25
-17.7%
46.5%
Q1 25
48.4%
26.0%
Q4 24
0.6%
Q3 24
10.8%
48.2%
Q2 24
35.4%
27.9%
Q1 24
60.0%
14.0%
Capex Intensity
IRWD
IRWD
MITK
MITK
Q4 25
0.0%
3.2%
Q3 25
0.0%
0.6%
Q2 25
0.0%
0.7%
Q1 25
0.1%
0.4%
Q4 24
0.0%
0.9%
Q3 24
0.0%
0.7%
Q2 24
0.1%
1.0%
Q1 24
0.1%
1.0%
Cash Conversion
IRWD
IRWD
MITK
MITK
Q4 25
2.89×
Q3 25
1.19×
10.46×
Q2 25
-0.64×
9.00×
Q1 25
1.50×
Q4 24
6.74×
Q3 24
2.71×
2.46×
Q2 24
60.12×
Q1 24
25.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

MITK
MITK

Fraud And Identity Solutions$25.5M58%
License$13.9M31%
Fraud And Identity Solutions Software License And Support$3.9M9%
Professional Services And Other$1.2M3%

Related Comparisons